310 related articles for article (PubMed ID: 17889351)
21. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
22. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
23. The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant.
Schimmer AD; Dranitsaris G; Ali V; Falconer M; Keating A
Support Care Cancer; 2002 Apr; 10(3):247-52. PubMed ID: 11904790
[TBL] [Abstract][Full Text] [Related]
24. Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study.
Hermet E; Cabrespine A; Guièze R; Garnier A; Tempescul A; Lenain P; Bouabdallah R; Vilque JP; Frayfer J; Bordessoule D; Sibon D; Janvier M; Caillot D; Biron P; Legros L; Choufi B; Drenou B; Gorin NC; Bilger K; Tamburini J; Soussain C; Brechignac S; Bay JO;
J Geriatr Oncol; 2015 Sep; 6(5):346-52. PubMed ID: 26116168
[TBL] [Abstract][Full Text] [Related]
25. Autologous stem cell transplantation for malignant lymphomas.
Reményi P; Masszi T; Kriván G; Goda V; Réti M
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S104-6. PubMed ID: 9916651
[TBL] [Abstract][Full Text] [Related]
26. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Vose JM; Rizzo DJ; Tao-Wu J; Armitage JO; Bashey A; Burns LJ; Christiansen NP; Freytes CO; Gale RP; Gibson J; Giralt SA; Herzig RH; Lemaistre CF; McCarthy PL; Nimer SD; Petersen FB; Schenkein DP; Wiernik PH; Wiley JM; Loberiza FR; Lazarus HM; van Biesen K; Horowitz MM
Biol Blood Marrow Transplant; 2004 Feb; 10(2):116-27. PubMed ID: 14750077
[TBL] [Abstract][Full Text] [Related]
27. Impact of body mass index on pulmonary complications in patients with non-Hodgkin lymphoma treated with hematopoietic stem cell transplant.
Lin C; Lin J; Stavas M; Li S; Canady KJ; Romberger DJ; Loberiza FR
Leuk Lymphoma; 2015; 56(11):3058-64. PubMed ID: 25739939
[TBL] [Abstract][Full Text] [Related]
28. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
29. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Carter A; Robison LL; Francisco L; Smith D; Grant M; Baker KS; Gurney JG; McGlave PB; Weisdorf DJ; Forman SJ; Bhatia S
Bone Marrow Transplant; 2006 Jun; 37(11):1023-9. PubMed ID: 16604098
[TBL] [Abstract][Full Text] [Related]
31. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
[TBL] [Abstract][Full Text] [Related]
32. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
[TBL] [Abstract][Full Text] [Related]
33. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of moderate-grade and high-grade malignant lymphoma with autologous hematopoietic stem cell transplantation].
Wang AL; He ZD; Luo Y; Xiao LX; Liu XY; Zhu YH
Ai Zheng; 2003 Dec; 22(12):1317-20. PubMed ID: 14693059
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Buchbinder D; Brazauskas R; Bo-Subait K; Ballen K; Parsons S; John T; Hahn T; Sharma A; Steinberg A; D'Souza A; Kumar AJ; Yoshimi A; Wirk B; Shaw B; Freytes C; LeMaistre C; Bredeson C; Dandoy C; Almaguer D; Marks DI; Szwajcer D; Hale G; Schouten H; Hashem H; Schoemans H; Murthy HS; Lazarus HM; Cerny J; Tay J; Yared JA; Adekola K; Schultz KR; Lehmann L; Burns L; Aljurf M; Diaz MA; Majhail N; Farhadfar N; Kamble R; Olsson R; Schears R; Seo S; Beattie S; Chhabra S; Savani BN; Badawy S; Ganguly S; Ciurea S; Marino S; Gergis U; Kuwatsuka Y; Inamoto Y; Khera N; Hashmi S; Wood W; Saber W
Biol Blood Marrow Transplant; 2020 Mar; 26(3):553-561. PubMed ID: 31726205
[TBL] [Abstract][Full Text] [Related]
37. [Allogeneic transplantation in malignant lymphoma].
Stötzer OJ; Schleuning M; Ledderose G; Hiddemann W; Kolb HJ
Dtsch Med Wochenschr; 2001 Sep; 126(39):1062-9. PubMed ID: 11602913
[TBL] [Abstract][Full Text] [Related]
38. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
39. Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Lazarus HM; Carreras J; Boudreau C; Loberiza FR; Armitage JO; Bolwell BJ; Freytes CO; Gale RP; Gibson J; Hale GA; Inwards DJ; LeMaistre CF; Maharaj D; Marks DI; Miller AM; Pavlovsky S; Schouten HC; van Besien K; Vose JM; Bitran JD; Khouri IF; McCarthy PL; Yu H; Rowlings P; Serna DS; Horowitz MM; Rizzo JD;
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1323-33. PubMed ID: 19041053
[TBL] [Abstract][Full Text] [Related]
40. Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up.
Bolwell B; Kalaycio M; Sobecks R; Andresen S; Mcbee M; Kuczkowski L; Rybicki L; Pohlman B
Bone Marrow Transplant; 2002 Apr; 29(8):673-9. PubMed ID: 12180112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]